Dimensional Fund Advisors’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $727K | Buy |
251,803
+64,028
| +34% | +$137K | ﹤0.01% | 2893 |
|
|
2025
Q4 | $302K | Sell |
187,775
-157,807
| -46% | -$248K | ﹤0.01% | 3042 |
|
|
2025
Q3 | $581K | Sell |
345,582
-163,221
| -32% | -$264K | ﹤0.01% | 2969 |
|
|
2025
Q2 | $616K | Sell |
508,803
-136,822
| -21% | -$198K | ﹤0.01% | 2960 |
|
|
2025
Q1 | $820K | Sell |
645,625
-71,663
| -10% | -$187K | ﹤0.01% | 2914 |
|
|
2024
Q4 | $2.33M | Sell |
717,288
-165,372
| -19% | -$596K | ﹤0.01% | 2750 |
|
|
2024
Q3 | $2.9M | Sell |
882,660
-15,837
| -2% | -$61.7K | ﹤0.01% | 2690 |
|
|
2024
Q2 | $3.82M | Sell |
898,497
-152,762
| -15% | -$1.49M | ﹤0.01% | 2581 |
|
|
2024
Q1 | $15.5M | Sell |
1,051,259
-163,641
| -13% | -$2.47M | ﹤0.01% | 2114 |
|
|
2023
Q4 | $11.7M | Sell |
1,214,900
-6,345
| -0.5% | -$43.9K | ﹤0.01% | 2251 |
|
|
2023
Q3 | $5.69M | Sell |
1,221,245
-18,070
| -1% | -$90K | ﹤0.01% | 2491 |
|
|
2023
Q2 | $6.63M | Buy |
1,239,315
+173,012
| +16% | +$1.07M | ﹤0.01% | 2428 |
|
|
2023
Q1 | $7.65M | Buy |
1,066,303
+310,479
| +41% | +$1.87M | ﹤0.01% | 2333 |
|
|
2022
Q4 | $5.07K | Buy |
755,824
+285,731
| +61% | +$1.57M | ﹤0.01% | 2448 |
|
|
2022
Q3 | $1.63M | Sell |
470,093
-445,801
| -49% | -$1.71M | ﹤0.01% | 2769 |
|
|
2022
Q2 | $2.7M | Sell |
915,894
-244,458
| -21% | -$1.28M | ﹤0.01% | 2648 |
|
|
2022
Q1 | $10.2M | Sell |
1,160,352
-75,524
| -6% | -$834K | ﹤0.01% | 2291 |
|
|
2021
Q4 | $19.8M | Buy |
1,235,876
+18,792
| +2% | +$354K | 0.01% | 1994 |
|
|
2021
Q3 | $25.5M | Sell |
1,217,084
-61,220
| -5% | -$1.47M | 0.01% | 1880 |
|
|
2021
Q2 | $34.3M | Buy |
1,278,304
+166,071
| +15% | +$4.86M | 0.01% | 1730 |
|
|
2021
Q1 | $35.4M | Sell |
1,112,233
-112,615
| -9% | -$2.73M | 0.01% | 1697 |
|
|
2020
Q4 | $28M | Sell |
1,224,848
-135,937
| -10% | -$3.13M | 0.01% | 1805 |
|
|
2020
Q3 | $34.3M | Sell |
1,360,785
-6,541
| -0.5% | -$179K | 0.01% | 1493 |
|
|
2020
Q2 | $38.2M | Buy |
1,367,326
+8,731
| +0.6% | +$152K | 0.02% | 1433 |
|
|
2020
Q1 | $7.91M | Buy |
1,358,595
+53,858
| +4% | +$489K | ﹤0.01% | 2219 |
|
|
2019
Q4 | $14.2M | Buy |
1,304,737
+10,577
| +0.8% | +$105K | 0.01% | 2204 |
|
|
2019
Q3 | $16.5M | Buy |
1,294,160
+31,617
| +3% | +$455K | 0.01% | 2116 |
|
|
2019
Q2 | $21.4M | Buy |
1,262,543
+128,786
| +11% | +$2.21M | 0.01% | 2008 |
|
|
2019
Q1 | $20.4M | Buy |
1,133,757
+325,556
| +40% | +$5.63M | 0.01% | 2040 |
|
|
2018
Q4 | $10.3M | Buy |
808,201
+225,690
| +39% | +$3.78M | ﹤0.01% | 2332 |
|
|
2018
Q3 | $12.5M | Buy |
582,511
+293,527
| +102% | +$6.26M | ﹤0.01% | 2338 |
|
|
2018
Q2 | $5.97M | Sell |
288,984
-500
| -0.2% | -$11.3K | ﹤0.01% | 2608 |
|
|
2018
Q1 | $7.28M | Hold |
289,484
| – | – | ﹤0.01% | 2486 |
|
|
2017
Q4 | $5.5M | Buy |
289,484
+5,967
| +2% | +$111K | ﹤0.01% | 2588 |
|
|
2017
Q3 | $5.24M | Buy |
283,517
+102,778
| +57% | +$1.78M | ﹤0.01% | 2582 |
|
|
2017
Q2 | $3.17M | Buy |
180,739
+137,167
| +315% | +$2.62M | ﹤0.01% | 2735 |
|
|
2017
Q1 | $810K | Buy |
+43,572
| New | +$841K | ﹤0.01% | 3015 |
|
Other funds holding MGNX
AC
VCM
RCM
WA
Dimensional Fund Advisors's MGNX Position: Q1 2026 in Review
Dimensional Fund Advisors increased its MacroGenics (MGNX) stake by 34% in Q1 2026, buying an estimated $137K and bringing the position to 251,803 shares worth $727K. The position accounts for ﹤0.01% of the portfolio, ranked #2893.
Dimensional Fund Advisors first reported a position in MGNX in Q1 2017 and has held it in 37 quarters since. The position peaked at $38.2M in Q2 2020. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.
- Dimensional Fund Advisors held 251,803 shares of MacroGenics worth $727K as of Q1 2026.
- Dimensional Fund Advisors bought 64,028 MacroGenics shares in Q1 2026, an estimated $137K.
- MacroGenics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2893 holding.
- Dimensional Fund Advisors first reported a position in MacroGenics in Q1 2017 and has held it in 37 quarters since.
- Dimensional Fund Advisors's MacroGenics position peaked at $38.2M in Q2 2020.
- 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.